BU Faculty comment on various implications of the pandemic on non-COVID-19 trials
The course of clinical trials research has been impacted to varying extents by the COVID-19 pandemic. The Hariri Institute for Computing, Department of Biostatistics (SPH), the Statistics Program, and Department of Mathematics and Statistics (CAS) at Boston University have organized an event where BU Statistic faculty will have the opportunity to comment on various implications of the pandemic on non-COVID-19 trials.
Please join us for this event on Monday, December 7th from 12:30pm – 2:00pm. Below is the detailed program:
12:30pm – 12:40pm – Welcome & Introductions [Eric Kolaczyk, Hariri Institute Director]
12:40pm – 1:00pm – FDA/EMA-level guidance – a summary [Joe Massaro, Biostatistics]
1:00pm – 1:20pm – Statistical issues and recommendations – some nuts and bolts [Ludovic Trinquart, Biostatistics]
1:20pm – 1:40pm – Adaptive designs and causal methods — ready-made solutions? [Judith Lok, Mathematics & Statistics]
1:40pm – 2:00pm – Q&A
Zoom Webinar ID: 955 7170 5247
To learn more about this virtual event, visit here.